Mutations in isocitrate dehydrogenase (IDH)1 and IDH2 are found in 6%–16% and 8%–19% of patients with acute myeloid leukemia (AML), respectively (Bruno et al., 2016). This evidence concerns the gene IDH3A and acute myeloid leukemia.